Law & Arbitration · Industry Arbitration
Pharmaceutical Arbitration Lawyers
Life sciences disputes, resolved with scientific and legal precision.
Handle’s pharmaceutical arbitration lawyers act for manufacturers, distributors, research partners and investors in licensing, supply, clinical and IP disputes — run before arbitral tribunals with MOHAP and DOH requirements in view and awards enforced in the UAE and abroad.
When this is needed
Pharmaceutical Arbitration Lawyers in the UAE: where the mandate begins.
- A licensing, manufacturing or supply agreement has failed on performance, quality or delivery, and continuity of supply is at risk.
- A clinical trial or research collaboration has broken down over data, IP ownership or funding.
- A distribution or exclusivity arrangement is being terminated or challenged, with regulatory and competition consequences.
- A patent, process or formula is being used outside the licence, and rights must be enforced through arbitration.
Matters Handle leads
Pharmaceutical arbitration mandates.
Four mandate types. One life sciences dispute, led to an enforceable award.
Licensing & Supply Disputes
Contractual, performance, quality and delivery claims.
Clinical Trial & Research Arbitration
Data integrity, IP and collaboration claims.
Distribution & Regulatory Disputes
Exclusivity, compliance and competition-related claims.
Pharma Award Enforcement
UAE and global recognition of arbitral decisions.
The scope
Pharmaceutical Arbitration Lawyers — scope, made explicit.
A focused, premium mandate — with the product, its licence and its supply chain at the center.
Pre-Arbitration Review
Contracts and regulatory position reviewed to limit exposure.
Technical Evidence
GMP, quality control and performance evidence secured with experts.
IP & Patent Claims
Patent, process and formula rights enforced before tribunals.
Regulatory Coordination
MOHAP, DOH and pricing considerations managed alongside the claim.
Award Execution
Awards enforced through UAE courts and international treaties.
The mandate
Science on the record. Rights enforced.
Pharmaceutical disputes are decided on technical evidence and regulatory context. Handle’s pharmaceutical arbitration lawyers secure quality, clinical and IP evidence early and present it in terms a tribunal can apply.
Supply continuity and regulatory standing are protected while the claim runs, and enforcement is planned against the parties who must pay.
What the mandate delivers
- Manufacturing and supply chain arbitration
- Licensing and regulatory disputes
- Clinical research and IP arbitration
- Distribution and exclusivity claims
- Pre-arbitration compliance review
- Award recognition and execution
How the work runs
Four disciplines. One enforceable pharmaceutical award.
Every pharmaceutical arbitration mandate is run with technical, regulatory, procedural and enforcement control.
01
Technical Evidence
Quality, clinical and IP facts secured with the right experts.
02
Regulatory Alignment
MOHAP, DOH and pricing rules addressed in the claim.
03
Arbitral Advocacy
Licensing, supply and research disputes led before tribunals.
04
Award Enforcement
Execution through UAE courts and international treaties.
The Handle model
Practice-led. Never fragmented.
The dispute may begin in one sector — it stays connected to strategy, capital and law.
Strategy & Operations
The work stays connected to market position, operating model, performance and execution governance.
M&A & Capital
The work stays aware of capital readiness, investor review, transaction logic and deployment discipline where relevant.
Legal & Regulatory
The work stays protected through structure, rights, governance, enforceability and regulatory or dispute readiness.
Why Handle
Scientific precision. Legal discipline.
Handle’s pharmaceutical arbitration lawyers combine command of life sciences contracts and regulation with institutional arbitration discipline — and keep every dispute connected to the product pipeline and capital behind it.
- Pharma licensing and manufacturing arbitration
- Clinical, research and compliance disputes
- Cross-border IP and regulatory enforcement
- Scientific and legal risk management integrated
- Institutional rigour in award enforcement
- Partner-led mandates with institutional discipline
Good litigation is disciplined project management. Clear filings, clean evidence, and a hearing plan that your board understands. That is how outcomes travel from courtroom to cash.
Hamda Al FalasiPartner, Law & Arbitration
Engagement paths
Where this work typically begins.
Growth & Expansion
When the asset must scale capacity, geography, capital, partnerships or market share.
Turnaround
When the asset must reset structure, capital, law, governance and operations under pressure.
Coverage
Pharmaceutical arbitration across the UAE and international seats.
Handle’s pharmaceutical arbitration lawyers act before DIAC, ICC and LCIA tribunals, the DIFC and ADGM Courts and the UAE courts, with MOHAP and DOH requirements in view.
Forums · Courts & arbitration
Sector practice
Related service lines
Industry arbitration · Law & Arbitration
Infrastructure & Construction Arbitration LawyersFinancial Services Arbitration LawyersEnergy Arbitration LawyersHealthcare Arbitration LawyersManufacturing & Industrial Arbitration LawyersConsumer & Retail Arbitration LawyersTechnology Arbitration LawyersPublic Sector Arbitration LawyersPrivate Enterprises & Family Offices Arbitration LawyersAviation Arbitration LawyersMaritime Arbitration LawyersEcommerce Arbitration LawyersFashion Arbitration LawyersFood & Beverage Arbitration LawyersAutomotive Arbitration LawyersEducation Arbitration LawyersSports Arbitration LawyersTravel & Hospitality Arbitration LawyersEntertainment Arbitration LawyersNon Profit & NGO Arbitration LawyersLuxury Arbitration LawyersCrypto Arbitration LawyersInsurance Arbitration LawyersFintech Arbitration LawyersSaaS Arbitration LawyersYachting Arbitration LawyersHotels & Resorts Arbitration LawyersReal Estate Arbitration Lawyers
Questions, answered
Pharmaceutical Arbitration Lawyers — questions, answered.
How Handle’s pharmaceutical arbitration lawyers resolve life sciences disputes.
What disputes do Handle’s pharmaceutical arbitration lawyers manage?
Licensing, distribution, supply and joint venture disputes in the pharma sector.
Does Handle act for manufacturers and distributors?
Yes. Handle represents companies across the production and distribution chain.
Can Handle manage cross-border pharmaceutical arbitration?
Yes. Multi-jurisdictional disputes involving GCC, European and North American parties are coordinated.
Does Handle act in IP and patent arbitration?
Yes. Patent, process and formula protection is enforced internationally.
Can Handle arbitrate clinical trial or research disputes?
Yes. Disputes between investors, institutions and laboratories are managed.
Does Handle act in regulatory and pricing disputes?
Yes. Disputes involving MOHAP, DOH and pricing regulation are handled.
Can Handle enforce pharmaceutical arbitral awards?
Yes. Awards are executed through UAE courts and international treaties.
What defines Handle’s pharmaceutical arbitration strategy?
Scientific precision combined with legal discipline and enforceability.
Does Handle act in supply and quality control disputes?
Yes. Arbitration on GMP, quality control and performance standards is managed.
Does Handle conduct compliance reviews before arbitration?
Yes. Contracts and regulatory positions are reviewed to limit exposure.
Insights
Perspectives from live mandates.
Partner-led analysis on law, capital and strategy, shaped by boardroom realities across the UAE and the GCC.
Toku Launches UAE Unit as Talabat Scales Contact-Centre Rollout Across Eight MENA Markets
Toku Launches UAE Unit as Talabat Scales Contact-Centre Rollout Across Eight MENA Markets
Majid Al Futtaim Posts Record H1 EBITDA of AED 2.5 Billion as Growth Momentum Builds
Majid Al Futtaim Posts Record H1 EBITDA of AED 2.5 Billion as Growth Momentum Builds
UAE-Germany Investment Push: Al Jaber Calls for New Council to Unlock Long-Term Capital and Tech Growth
UAE-Germany Investment Push: Al Jaber Calls for New Council to Unlock Long-Term Capital and Tech Growth
Work with Handle
Begin with Pharmaceutical Arbitration Lawyers — kept connected to the whole Handle model.
When supply, licence and IP rights are in dispute.
Request an initial review
When a life sciences dispute must be controlled.
Set out the matter. A partner reviews it and responds with a defined route, legal strategy and accountable lead.
- Partner-level review of every request
- Strict confidentiality and privilege from first contact
- One accountable partner from review to execution
